We observed a slight but consistent preferential killing of WT over IFNγRKO tumour cells by OTI CD8+ T cells (Fig. 2L), consistent with the increase of MHC-I observed in the WT but not IFNγRKO tumour cells following IFNγ treatment (Fig. 2C). Here, CD8A is linked to neoplasm.